Position in LXRX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$15,600
+$4,100 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NBT BANK N A /NY holds $168,903 across 17 Biotechnology names. LXRX ranks #2 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
161 | $124,394 | |
| 2 | LXRX |
Lexicon Pharmaceuticals, Inc.
This page
|
10,000 | $15,600 | |
| 3 | ANIX |
Anixa Biosciences Inc
|
2,000 | $5,160 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11 | $4,911 | |
| 5 | ARGX |
Argenx SE
|
5 | $3,651 | |
| 6 | MRNA |
Moderna, Inc.
|
40 | $2,032 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
45 | $1,810 | |
| 8 | RPRX |
Royalty Pharma plc
|
34 | $1,630 |
All Filings in LXRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,600 | 10,000 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $11,500 | 10,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $13,500 | 10,000 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $9,500 | 10,000 | Shares | Sole | 2025-07-23 | |
| No filing history on record for this holder in this stock. | ||||||